Diclofenamide
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
MedlinePlus | a601233 |
ATC code | |
Pharmacokinetic data | |
Protein binding | 55% |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
ECHA InfoCard | 100.004.037 |
Chemical and physical data | |
Formula | C6H6Cl2N2O4S2 |
Molar mass | 305.16 g/mol |
3D model (JSmol) | |
Melting point | 228.5 °C (443.3 °F) |
| |
| |
(what is this?) (verify) |
Diclofenamide (or dichlorphenamide) is a sulfonamide and a carbonic anhydrase inhibitor of the meta-disulfamoylbenzene class.
Uses
Diclofenamide is used to treat glaucoma[1][2] and therapy-resistant epilepsy.[3]
References
- ↑ International Drug Names: Diclofenamide
- ↑ Kanski, J. J. (1968). "Carbonic anhydrase inhibitors and osmotic agents in glaucoma. Carbonic anhydrase inhibitors". The British journal of ophthalmology. 52 (8): 642–643. PMC 506660 . PMID 5724852. doi:10.1136/bjo.52.8.642.
- ↑ Rucquoy, M.; Sorel, L. (1978). "Diclofenamide in the treatment of therapy-resistant epilepsy". Acta Neurologica Belgica. 78 (3): 174–182. PMID 352085.
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.